Skip to main content

ADVERTISEMENT

Videos

Bienstock Figure
Clinical Videos
05/07/2024

Solomon W. Bienstock, MD; Kali Hopkins, MD; Barry Love, MD; Ali Zaidi, MD; Gina LaRocca, MD; George Dangas, MD, PhD; Stamatios Lerakis, MD, PhD

Solomon W. Bienstock, MD; Kali Hopkin...
Video Supplement to "Percutaneous Closure of a Sinus Venosus Defect With Partial Anomalous Pulmonary Venous Return" (Clinical Image)
Video Supplement to "Percutaneous Closure of a Sinus Venosus Defect With Partial Anomalous Pulmonary Venous Return" (Clinical Image)
Video Supplement to...
05/07/2024
Journal of Invasive Cardiology
Christian Rolfo, MD, PhD
Conference Coverage
05/07/2024

Featuring Christian Rolfo, MD, PhD

Featuring Christian Rolfo, MD, PhD ...
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Christian Rolfo, MD, PhD, argued that upfront liquid biopsies are an essential part of the initial patient workup.
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Christian Rolfo, MD, PhD, argued that upfront liquid biopsies are an essential part of the initial patient workup.
At the Great Debates and Updates...
05/07/2024
Oncology
Dr Zagrodzky discusses his session
Videos
05/06/2024

Interview by Jodie Elrod

Interview by Jodie Elrod
Dr Jason Zagrodzky discusses his session ahead of Heart Rhythm 2024, which takes place May 16-19, 2024.
Dr Jason Zagrodzky discusses his session ahead of Heart Rhythm 2024, which takes place May 16-19, 2024.
Dr Jason Zagrodzky discusses his...
05/06/2024
EP Lab Digest
Christian Rolfo, MD, PhD
Conference Coverage
05/06/2024

Featuring Christian Rolfo, MD, PhD

Featuring Christian Rolfo, MD, PhD ...
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Christian Rolfo, MD, PhD, argued that perioperative immunotherapy should not be used to treat patients with lung cancer.
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Christian Rolfo, MD, PhD, argued that perioperative immunotherapy should not be used to treat patients with lung cancer.
At the Great Debates and Updates...
05/06/2024
Oncology
 Noa Biran, MD, Hackensack Meridian Health
Conference Coverage
05/06/2024

Featuring Noa Biran, MD

Featuring Noa Biran, MD
Noa Biran, MD, evaluates a variety of treatment options for patients with relapsed/refractory multiple myeloma at the 2024 Great Debates & Updates in Hematologic Malignancies meeting.
Noa Biran, MD, evaluates a variety of treatment options for patients with relapsed/refractory multiple myeloma at the 2024 Great Debates & Updates in Hematologic Malignancies meeting.
Noa Biran, MD, evaluates a...
05/06/2024
Oncology
Sam Yamshon, MD, Weill Cornell Medicine
Conference Coverage
05/06/2024

Featuring Sam Yamshon, MD

Featuring Sam Yamshon, MD
Sam Yamshon, MD, discusses the safety of CAR T-cell therapy following the FDA’s warning in late 2023 regarding the risk of patients developing secondary T-cell malignancies following this treatment.
Sam Yamshon, MD, discusses the safety of CAR T-cell therapy following the FDA’s warning in late 2023 regarding the risk of patients developing secondary T-cell malignancies following this treatment.
Sam Yamshon, MD, discusses the...
05/06/2024
Oncology
Jennifer Amengual, MD, Columbia University
Conference Coverage
05/06/2024

Featuring Jennifer Amengual, MD

Featuring Jennifer Amengual, MD ...
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Jennifer Amengual, MD, discusses novel therapeutic targets for elderly patients with DLBCL who are not candidates for CAR T-cell therapy.
At the Lymphoma, Leukemia & Myeloma Congress in New York, New York, Jennifer Amengual, MD, discusses novel therapeutic targets for elderly patients with DLBCL who are not candidates for CAR T-cell therapy.
At the Lymphoma, Leukemia &...
05/06/2024
Oncology
BDHC thumbnail
Breaking Down Health Care
05/06/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part...
05/06/2024
Cancer Care Business Exchange
Balazs Halmos, MD, Montefiore Einstein Comprehensive Cancer Center
Conference Coverage
05/03/2024

Featuring Balazs Halmos, MD

Featuring Balazs Halmos, MD
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Balazs Halmos MD, discussed the addition of CTLA-4 inhibition in the treatment of STK-11– and KEAP-1–mutated lung cancer.
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Balazs Halmos MD, discussed the addition of CTLA-4 inhibition in the treatment of STK-11– and KEAP-1–mutated lung cancer.
At the Great Debates and Updates...
05/03/2024
Oncology
Edward Kaftarian, MD.
Videos
05/03/2024

Featuring Edward Kaftarian, MD

Featuring Edward Kaftarian, MD ...
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian,...
05/03/2024
Psych Congress Network